N. C. Andrews, Disorders of iron metabolism, N. Engl. J. Med, vol.341, 1986.

H. Gunshin, B. Mackenzie, U. V. Berger, Y. Gunshin, M. F. Romero et al., Cloning and characterization of a mammalian proton-coupled metal-ion transporter, Nature, vol.388, pp.482-488, 1997.

A. T. Mckie, D. Barrow, G. O. Latunde-dada, A. Rolfs, G. Sager et al., An Iron-Regulated Ferric Reductase Associated with the Absorption of Dietary Iron, Science, vol.291, pp.1755-1759, 2001.

M. Shayeghi, G. O. Latunde-dada, J. S. Oakhill, A. H. Laftah, K. Takeuchi et al., Identification of an intestinal heme transporter, Cell, vol.122, pp.789-801, 2005.

A. Qiu, M. Jansen, A. Sakaris, S. H. Min, S. Chattopadhyay et al., Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption, Cell, vol.127, pp.917-928, 2006.

G. Bergamaschi, A. Di-sabatino, A. Pasini, C. Ubezio, F. Costanzo et al., Intestinal expression of genes implicated in iron absorption and their regulation by hepcidin, Clin. Nutr. Edinb. Scotl, vol.36, pp.1427-1433, 2017.

T. H. Bothwell, G. Pirzio-biroli, and C. A. Finch, Iron absorption. I. Factors influencing absorption, J. Lab. Clin. Med, vol.51, pp.24-36, 1958.

A. T. Mckie, P. Marciani, A. Rolfs, K. Brennan, K. Wehr et al., A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation, Mol. Cell, vol.5, pp.299-309, 2000.

A. Donovan, A. Brownlie, Y. Zhou, J. Shepard, S. J. Pratt et al., Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter, Nature, vol.403, pp.776-781, 2000.

S. Abboud and D. J. Haile, A novel mammalian iron-regulated protein involved in intracellular iron metabolism, J. Biol. Chem, vol.275, 2000.

S. Osaki, D. A. Johnson, and E. Frieden, The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum, J. Biol. Chem, pp.2746-2751, 1966.

C. D. Vulpe, Y. M. Kuo, T. L. Murphy, L. Cowley, C. Askwith et al., Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse, Nat. Genet, vol.21, pp.195-199, 1999.

J. E. Levy, O. Jin, Y. Fujiwara, F. Kuo, and N. C. Andrews, Transferrin receptor is necessary for development of erythrocytes and the nervous system, Nat. Genet, vol.21, pp.396-399, 1999.

R. S. Ohgami, D. R. Campagna, E. L. Greer, B. Antiochos, A. Mcdonald et al., Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells, Nat. Genet, vol.37, pp.1264-1269, 2005.

C. Camaschella, A. Roetto, A. Cali, M. De-gobbi, G. Garozzo et al., The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22, Nat. Genet, vol.25, pp.14-15, 2000.

W. J. Griffiths and T. M. Cox, Co-localization of the mammalian hemochromatosis gene product (HFE) and a newly identified transferrin receptor (TFR2) in intestinal tissue and cells, J. Histochem. Cytochem, vol.51, pp.613-624, 2003.

A. Krause, S. Neitz, H. J. Magert, A. Schulz, W. G. Forssmann et al., LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity, FEBS Lett, vol.480, pp.147-150, 2000.

C. H. Park, E. V. Valore, A. J. Waring, and T. Ganz, Hepcidin, a urinary antimicrobial peptide synthesized in the liver, J. Biol. Chem, vol.276, pp.7806-7810, 2001.

C. Pigeon, G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin et al., A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload, J. Biol. Chem, vol.276, pp.7811-7819, 2001.

E. Nemeth, M. S. Tuttle, J. Powelson, M. B. Vaughn, A. Donovan et al., Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, vol.306, pp.2090-2093, 2004.

G. Nicolas, M. Bennoun, I. Devaux, C. Beaumont, B. Grandchamp et al., Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice, Proc. Natl. Acad. Sci, vol.98, pp.8780-8785, 2001.
URL : https://hal.archives-ouvertes.fr/inserm-00331349

E. Nemeth, S. Rivera, V. Gabayan, C. Keller, S. Taudorf et al., IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin, J. Clin. Investig, vol.113, pp.1271-1276, 2004.

G. Nicolas, L. Viatte, M. Bennoun, C. Beaumont, A. Kahn et al., A New Iron Regulatory Peptide, Blood Cells Mol. Dis, vol.29, pp.327-335, 2002.

C. Peyssonnaux, V. Nizet, and R. S. Johnson, Role of the hypoxia inducible factors HIF in iron metabolism, Cell Cycle, vol.7, pp.28-32, 2008.

L. Kautz, G. Jung, E. V. Valore, S. Rivella, E. Nemeth et al., Identification of erythroferrone as an erythroid regulator of iron metabolism, Nat. Genet, vol.46, pp.678-684, 2014.

S. G. Gehrke, H. Kulaksiz, T. Herrmann, H. D. Riedel, K. Bents et al., Expression of hepcidin in hereditary hemochromatosis: Evidence for a regulation in response to serum transferrin saturation and non-transferrin-bound iron, Blood, vol.102, pp.371-376, 2003.

G. Ramey, J. C. Deschemin, and S. Vaulont, Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes, Haematologica, vol.94, pp.765-772, 2009.

J. N. Feder, Z. Tsuchihashi, A. Irrinki, V. K. Lee, F. A. Mapa et al., The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression, J. Biol. Chem, vol.272, pp.14025-14028, 1997.

J. N. Feder, D. M. Penny, A. Irrinki, V. K. Lee, J. A. Lebron et al., The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding, Proc. Natl. Acad. Sci, vol.95, pp.1472-1477, 1998.

P. J. Schmidt, P. T. Toran, A. M. Giannetti, P. J. Bjorkman, and N. C. Andrews, The transferrin receptor modulates HFE-dependent regulation of hepcidin expression, Cell Metab, vol.7, pp.205-214, 2008.

T. Goswami and N. C. Andrews, Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing, J. Biol. Chem, vol.281, pp.28494-28498, 2006.

P. J. Schmidt and M. D. Fleming, Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2, Am. J. Hematol, vol.87, pp.588-595, 2012.

D. Meynard, L. Kautz, V. Darnaud, F. Canonne-hergaux, H. Coppin et al., Lack of the bone morphogenetic protein BMP6 induces massive iron overload, Nat. Genet, vol.41, pp.478-481, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00385005

B. Andriopoulos, . Jr, E. Corradini, Y. Xia, S. A. Faasse et al., BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism, Nat. Genet, vol.41, pp.482-487, 2009.

G. Casanovas, K. Mleczko-sanecka, S. Altamura, M. W. Hentze, and M. U. Muckenthaler, Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD, J. Mol. Med, vol.87, pp.471-480, 2009.

M. L. Island, A. M. Jouanolle, A. Mosser, Y. Deugnier, V. David et al., A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis, Haematologica, vol.94, pp.720-724, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00372237

S. Canali, K. B. Zumbrennen-bullough, A. B. Core, C. Wang, M. Nairz et al., Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice, vol.129, pp.405-414, 2017.

M. Rausa, A. Pagani, A. Nai, A. Campanella, M. E. Gilberti et al., Bmp6 expression in murine liver non parenchymal cells: A mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?, PLoS ONE, vol.10, 2015.

P. Koch, V. Olsavszky, F. Ulbrich, C. Sticht, A. Demory et al., Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis, vol.129, pp.415-419, 2017.

R. H. Wang, C. Li, X. Xu, Y. Zheng, C. Xiao et al., A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression, Cell Metab, vol.2, pp.399-409, 2005.

L. Kautz, D. Meynard, A. Monnier, V. Darnaud, R. Bouvet et al., Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver, Blood, vol.112, pp.1503-1509, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00298517

M. V. Verga-falzacappa, G. Casanovas, M. W. Hentze, and M. U. Muckenthaler, A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells, J. Mol. Med, vol.86, pp.531-540, 2008.

F. D'alessio, M. W. Hentze, and M. U. Muckenthaler, The hemochromatosis proteins HFE, TFR2, and HJV form a membrane-associated protein complex for hepcidin regulation, J. Hepatol, vol.57, pp.1052-1060, 2012.

K. Pantopoulos, Iron regulation of hepcidin through HFE and HJV: Common or distinct pathways? Hepatology, vol.62, pp.1922-1923, 2015.

P. Brissot and O. Loreal, Iron metabolism and related genetic diseases: A cleared land, keeping mysteries, J. Hepatol, vol.64, pp.505-515, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01231421

H. Hamdi-roze, M. P. Beaumont-epinette, Z. Ben-ali, C. Le-lan, V. Loustaud-ratti et al., Rare HFE variants are the most frequent cause of hemochromatosis in non-c282y homozygous patients with hemochromatosis, Am. J. Hematol, vol.91, pp.1202-1205, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01427007

P. Brissot, A. Pietrangelo, P. C. Adams, B. De-graaff, C. E. Mclaren et al., Nat. Rev. Dis. Primer, 2018.

K. J. Allen, L. C. Gurrin, C. C. Constantine, N. J. Osborne, M. B. Delatycki et al., Iron-overload-related disease in HFE hereditary hemochromatosis, N. Engl. J. Med, vol.358, pp.221-230, 2008.

B. A. Van-dijk, C. M. Laarakkers, S. M. Klaver, E. M. Jacobs, L. J. Van-tits et al., Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels, Br. J. Haematol, vol.142, pp.979-985, 2008.

M. W. Hentze and L. C. Kuhn, Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress, Proc. Natl. Acad. Sci, vol.93, pp.8175-8182, 1996.

P. Ponka, Cellular iron metabolism, Kidney Int. Suppl, vol.69, 1999.

P. Ponka and C. N. Lok, The transferrin receptor: Role in health and disease, Int. J. Biochem. Cell Biol, vol.31, pp.1111-1137, 1999.

P. Arosio, F. Carmona, R. Gozzelino, F. Maccarinelli, and M. Poli, The importance of eukaryotic ferritins in iron handling and cytoprotection, Biochem. J, vol.472, pp.1-15, 2015.

C. Hershko and T. E. Peto, Non-transferrin plasma iron, Br. J. Haematol, vol.66, pp.149-151, 1987.

O. Loreal, I. Gosriwatana, D. Guyader, J. Porter, P. Brissot et al., Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method, J. Hepatol, vol.32, pp.727-733, 2000.

M. Grootveld, J. D. Bell, B. Halliwell, O. I. Aruoma, A. Bomford et al., Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy, J. Biol. Chem, vol.264, pp.4417-4422, 1989.

J. P. Liuzzi, F. Aydemir, H. Nam, M. D. Knutson, and R. J. Cousins, Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells, Proc. Natl. Acad. Sci, vol.103, pp.13612-13617, 2006.

P. Brissot, T. L. Wright, W. L. Ma, and R. A. Weisiger, Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states, J. Clin. Investig, vol.76, pp.1463-1470, 1985.

P. Brissot, U. Bolder, C. D. Schteingart, J. Arnaud, and A. F. Hofmann, Intestinal absorption and enterohepatic cycling of biliary iron originating from plasma non-transferrin-bound iron in rats, Hepatology, vol.25, pp.1457-1461, 1997.

N. Hubert, G. Lescoat, R. Sciot, R. Moirand, P. Jego et al., Regulation of ferritin and transferrin receptor expression by iron in human hepatocyte cultures, J. Hepatol, vol.18, pp.301-312, 1993.

R. Sciot, G. Verhoeven, P. Van-eyken, J. Cailleau, and V. J. Desmet, Transferrin receptor expression in rat liver: Immunohistochemical and biochemical analysis of the effect of age and iron storage, Hepatology, vol.11, pp.416-427, 1990.

S. Jenkitkasemwong, C. Y. Wang, R. Coffey, W. Zhang, A. Chan et al., SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis, Cell Metab, vol.22, pp.138-150, 2015.

A. Roetto, G. Papanikolaou, M. Politou, F. Alberti, D. Girelli et al., Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis, Nat. Genet, vol.33, pp.221-222, 2003.

G. Papanikolaou, M. E. Samuels, E. H. Ludwig, M. L. Macdonald, P. L. Franchini et al., Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis, Nat. Genet, vol.36, pp.77-82, 2004.

E. Bardou-jacquet, S. Cunat, M. Beaumont-epinette, C. Kannengiesser, X. Causse et al., Variable age of onset and clinical severity in transferrin receptor 2 related haemochromatosis: Novel observations, Br. J. Haematol, vol.162, pp.278-281, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00836894

C. Niederau, R. Fischer, A. Sonnenberg, W. Stremmel, H. J. Trampisch et al., Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis, N. Engl. J. Med, vol.313, pp.1256-1262, 1985.

C. Niederau, R. Fischer, A. Purschel, W. Stremmel, D. Haussinger et al., Long-term survival in patients with hereditary hemochromatosis, Gastroenterology, vol.110, pp.1107-1119, 1996.

O. Loreal, Y. Deugnier, R. Moirand, L. Lauvin, D. Guyader et al., Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients, J. Hepatol, vol.16, pp.122-127, 1992.

D. Guyader, C. Jacquelinet, R. Moirand, B. Turlin, M. H. Mendler et al., Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis, Gastroenterology, vol.115, pp.929-936, 1998.

Y. M. Deugnier, O. Loreal, B. Turlin, D. Guyader, H. Jouanolle et al., Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations, Gastroenterology, vol.102, pp.2050-2059, 1992.

S. J. Dixon, K. M. Lemberg, M. R. Lamprecht, R. Skouta, E. M. Zaitsev et al., Ferroptosis: An iron-dependent form of nonapoptotic cell death, Cell, vol.149, pp.1060-1072, 2012.

S. J. Dixon and B. R. Stockwell, The role of iron and reactive oxygen species in cell death, Nat. Chem. Biol, vol.10, pp.9-17, 2014.

K. Houglum, P. Bedossa, and M. Chojkier, TGF-beta and collagen-alpha 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload, Am. J. Physiol, vol.267, pp.908-913, 1994.

R. Gualdi, G. Casalgrandi, G. Montosi, E. Ventura, and A. Pietrangelo, Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis, Gastroenterology, vol.107, pp.1118-1124, 1994.

Y. M. Deugnier, D. Guyader, L. Crantock, J. M. Lopez, B. Turlin et al., Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases, Gastroenterology, vol.104, pp.228-234, 1993.

P. Guggenbuhl, P. Brissot, and O. Loreal, Miscellaneous non-inflammatory musculoskeletal conditions. Haemochromatosis: The bone and the joint, Best Pract. Res. Clin. Rheumatol, vol.25, pp.6649-6664, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01134838

P. Wardman and L. P. Candeias, Fenton chemistry: An introduction, Radiat. Res, vol.145, pp.523-531, 1996.

B. R. Bacon and R. S. Britton, Hepatic injury in chronic iron overload. Role of lipid peroxidation, Chem. Biol. Interact, vol.70, pp.183-226, 1989.

B. R. Bacon, A. S. Tavill, G. M. Brittenham, C. H. Park, and R. O. Recknagel, Hepatic lipid peroxidation in vivo in rats with chronic iron overload, J. Clin. Investig, vol.71, pp.429-439, 1983.

B. R. Bacon, R. O'neill, and R. S. Britton, Hepatic mitochondrial energy production in rats with chronic iron overload, Gastroenterology, vol.105, pp.1134-1140, 1993.

L. Lan, C. Loreal, O. Cohen, T. Ropert, M. Glickstein et al., Redox active plasma iron in C282Y/C282Y hemochromatosis, Blood, vol.105, pp.4527-4531, 2005.

Z. I. Cabantchik, W. Breuer, G. Zanninelli, and P. Cianciulli, LPI-labile plasma iron in iron overload, Best Pr. Res. Clin. Haematol, vol.18, pp.277-287, 2005.

J. Milet, V. Dehais, C. Bourgain, A. M. Jouanolle, A. Mosser et al., Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance, Am. J. Hum. Genet, vol.81, pp.799-807, 2007.

M. De-tayrac, M. Roth, A. Jouanolle, H. Coppin, G. Le-gac et al., Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis, J. Hepatol, vol.62, pp.664-672, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01091987

C. E. Mclaren, M. J. Emond, V. N. Subramaniam, P. D. Phatak, J. C. Barton et al., Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload, Hepatology, vol.62, pp.429-439, 2015.

D. Tchernitchko, V. Scotet, T. Lefebvre, C. L'hostis, I. Gourlaouen et al., GNPAT polymorphism rs11558492 is not associated with increased severity in a large cohort of HFE p.Cys282Tyr homozygous patients, Hepatology, vol.65, pp.1069-1071, 2017.

A. Levstik, A. Stuart, and P. Adams, GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis, Ann. Hepatol, vol.15, pp.907-910, 2016.

F. Greni, L. Valenti, R. Mariani, I. Pelloni, R. Rametta et al., GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors, Ann. Hepatol, vol.16, pp.451-456, 2017.

L. M. Fletcher, J. L. Dixon, D. M. Purdie, L. W. Powell, and D. H. Crawford, Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis, Gastroenterology, vol.122, pp.281-289, 2002.

J. E. Nelson, R. Bhattacharya, K. D. Lindor, N. Chalasani, S. Raaka et al., HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis, Hepatology, vol.46, pp.723-729, 2007.

T. Pollicino, A. Vegetti, C. Saitta, F. Ferrara, E. Corradini et al., Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma, J. Hepatol, vol.58, pp.190-193, 2013.

H. H. Diwakaran, A. S. Befeler, R. S. Britton, E. M. Brunt, and B. R. Bacon, Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection, J. Hepatol, vol.36, pp.687-691, 2002.

F. Stickel, S. Buch, H. Zoller, R. Hultcrantz, S. Gallati et al., Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis, Hum. Mol. Genet, vol.23, pp.3883-3890, 2014.

L. Valenti, P. Maggioni, A. Piperno, R. Rametta, S. Pelucchi et al., Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis, World J. Gastroenterol, vol.18, pp.2813-2820, 2012.

P. Adams, A. Altes, P. Brissot, B. Butzeck, I. Cabantchik et al., Contributors and Hemochromatosis International Taskforce Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, Hepatol. Int, vol.12, pp.83-86, 2018.

L. Falize, A. Guillygomarc'h, M. Perrin, F. Laine, D. Guyader et al., Reversibility of hepatic fibrosis in treated genetic hemochromatosis: A study of 36 cases, Hepatology, vol.44, pp.472-477, 2006.

P. Phatak, P. Brissot, M. Wurster, P. C. Adams, H. L. Bonkovsky et al., A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis, Hepatology, vol.52, pp.1671-1779, 2010.

E. Rombout-sestrienkova, G. H. Koek, R. Neslo, M. Van-kraaij, P. P. Menheere et al., Course of iron parameters in HFE-hemochromatosis patients during initial treatment with erythrocytapheresis compared to phlebotomy, J. Clin. Apheresis, vol.31, pp.564-570, 2016.

A. E. Mast, K. S. Schlumpf, D. J. Wright, B. Johnson, S. A. Glynn et al., NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy, Haematologica, vol.98, 2013.

J. P. Kaltwasser, E. Werner, K. Schalk, C. Hansen, R. Gottschalk et al., Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis, Gut, vol.43, pp.699-704, 1998.

S. Ludwiczek, I. Theurl, M. U. Muckenthaler, M. Jakab, S. M. Mair et al., Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1, Nat. Med, vol.13, pp.448-454, 2007.

A. Vanclooster, C. Van-deursen, R. Jaspers, D. Cassiman, and G. Koek, Proton Pump Inhibitors Decrease Phlebotomy Need in HFE Hemochromatosis: Double-Blind Randomized Placebo-Controlled Trial, Gastroenterology, vol.153, pp.678-680, 2017.

H. R. Schumacher, Articular cartilage in the degenerative arthropathy of hemochromatosis, Arthritis Rheum, vol.25, pp.1460-1468, 1982.

G. R. Heiland, E. Aigner, T. Dallos, E. Sahinbegovic, V. Krenn et al., Synovial immunopathology in haemochromatosis arthropathy, Ann. Rheum. Dis, vol.69, pp.1214-1219, 2010.

G. J. Carroll, G. Sharma, A. Upadhyay, and J. A. Jazayeri, Ferritin concentrations in synovial fluid are higher in osteoarthritis patients with HFE gene mutations (C282Y or H63D), Scand. J. Rheumatol, vol.39, pp.413-420, 2010.

A. Reuben, J. W. Chung, R. Lapointe, and M. M. Santos, The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune system, Immun. Inflamm. Dis, vol.5, pp.218-232, 2017.

E. Bardou-jacquet, F. Lainé, P. Guggenbuhl, J. Morcet, C. Jézéquel et al., Worse Outcomes of Patients with HFE Hemochromatosis With Persistent Increases in Transferrin Saturation During Maintenance Therapy, Clin. Gastroenterol. Hepatol, vol.15, pp.1620-1627, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01613515

E. Bardou-jacquet, J. Philip, R. Lorho, M. Ropert, M. Latournerie et al., Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis, Hepatology, vol.59, pp.839-847, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00876626

G. C. Preza, P. Ruchala, R. Pinon, E. Ramos, B. Qiao et al., Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload, J. Clin. Investig, vol.121, pp.4880-4888, 2011.

E. Corradini, P. J. Schmidt, D. Meynard, C. Garuti, G. Montosi et al., BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in HFE knockout mice, Gastroenterology, vol.139, pp.1721-1729, 2010.

S. Guo, C. Casu, S. Gardenghi, S. Booten, M. Aghajan et al., Reducing TMPRSS6 ameliorates hemochromatosis and ?-thalassemia in mice, J. Clin. Investig, vol.123, pp.1531-1541, 2013.

S. L. Ross, K. Biswas, J. Rottman, J. R. Allen, J. Long et al., Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction, Front. Pharmacol, vol.8, 2017.